Revolutionizing Cell Preservation: Alpha Teknova and Pluristyx Partner to Offer PluriFreeze™ Cryopreservation System
HOLLISTER, Calif., March 19, 2025 – Alpha Teknova, Inc. (Nasdaq: TKNO), a leading provider of advanced cell-based solutions, and Pluristyx, Inc., a pioneering company in the field of cryopreservation, are thrilled to announce an exclusive partnership. Pluristyx’s groundbreaking PluriFreeze™ cryopreservation system is now available for purchase through Alpha Teknova.
PluriFreeze™: A Game-Changer in Cryopreservation
PluriFreeze™, developed by Pluristyx, is a revolutionary cryopreservation system designed to maintain the viability and functionality of various types of cells, including stem cells, for an extended period. The system utilizes a proprietary method that prevents ice crystal formation during the freezing process, which is a common issue that can damage cells.
Benefits for the Scientific Community
The collaboration between Alpha Teknova and Pluristyx promises to significantly impact the scientific community. Researchers and biotech companies will now have access to a reliable and efficient cryopreservation system that can help advance their projects. This is particularly crucial for studies involving stem cells and other delicate cell types, which require optimal preservation to ensure their full potential.
Impact on Individuals
Beyond scientific research, the availability of PluriFreeze™ through Alpha Teknova could also have a profound impact on individuals. For instance, this technology could be used for the cryopreservation of umbilical cord blood and cord tissue, providing families with the opportunity to secure potential future medical treatments for their children. Furthermore, it may also pave the way for the eventual preservation of entire organs for transplant purposes.
Global Implications
The partnership between Alpha Teknova and Pluristyx could have far-reaching consequences for the world. Cryopreservation technology has the potential to revolutionize various industries, including medicine, agriculture, and biotechnology. By making PluriFreeze™ more accessible, the collaboration could lead to advancements in regenerative medicine, food preservation, and the production of bioengineered organisms.
Conclusion
Alpha Teknova’s partnership with Pluristyx marks a significant milestone in the field of cryopreservation. With PluriFreeze™ now available for purchase, researchers, businesses, and individuals alike can take advantage of this innovative technology. The potential applications are vast, spanning from scientific research to personal preservation and beyond. Together, Alpha Teknova and Pluristyx are poised to make a difference in the world, one frozen cell at a time.
- Alpha Teknova partners with Pluristyx to offer PluriFreeze™ cryopreservation system
- PluriFreeze™ maintains cell viability and functionality during freezing process
- Benefits for scientific community, individuals, and industries
- Potential applications in regenerative medicine, food preservation, and biotechnology
